Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Göran Rådegran

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Lakartidningen|September 9, 2021
[National consensus created regarding PAH and CTEPH care]Göran Rådegran
Lakartidningen|October 17, 2018
[Riskstratification in pulmonary arterial hypertension - renders better treatment and prognosis at highly specialised centers]Göran Rådegran
Lakartidningen|June 14, 2019
[Pulmonary hypertension due to left heart disease - not to be confused with pulmonary arterial hypertension]Jakob Lundgren, Göran Rådegran
Lakartidningen|July 26, 2017
[Pulmonary hypertension due to lung diseases]David Kylhammar, Göran Rådegran
Lakartidningen|January 3, 2018
[Pulmonary hypertension – a common condition in left heart disease]Jakob Lundgren, Göran Rådegran
The Japanese Journal of Physiology|March 31, 2005
Alterations in the rheological flow profile in conduit femoral artery during rhythmic thigh muscle contractions in humansTakuya Osada, Göran Rådegran
Lakartidningen|April 18, 2018
[50 years of heart transplantations]Carl Söderlund, Göran Rådegran
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2002
Femoral artery inflow in relation to external and total work rate at different knee extensor contraction ratesTakuya Osada, Göran Rådegran
Transplantation Reviews (Orlando, Fla.)|September 4, 2017
Osteoporosis following heart transplantation and immunosuppressive therapyEveline Löfdahl, Göran Rådegran
ERJ Open Research|November 17, 2018
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertensionHabib Bouzina, Göran Rådegran
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Lakartidningen|September 9, 2021
[National consensus created regarding PAH and CTEPH care]Göran Rådegran
Lakartidningen|October 17, 2018
[Riskstratification in pulmonary arterial hypertension - renders better treatment and prognosis at highly specialised centers]Göran Rådegran
Lakartidningen|June 14, 2019
[Pulmonary hypertension due to left heart disease - not to be confused with pulmonary arterial hypertension]Jakob Lundgren, Göran Rådegran
Lakartidningen|July 26, 2017
[Pulmonary hypertension due to lung diseases]David Kylhammar, Göran Rådegran
Lakartidningen|January 3, 2018
[Pulmonary hypertension – a common condition in left heart disease]Jakob Lundgren, Göran Rådegran
The Japanese Journal of Physiology|March 31, 2005
Alterations in the rheological flow profile in conduit femoral artery during rhythmic thigh muscle contractions in humansTakuya Osada, Göran Rådegran
Lakartidningen|April 18, 2018
[50 years of heart transplantations]Carl Söderlund, Göran Rådegran
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2002
Femoral artery inflow in relation to external and total work rate at different knee extensor contraction ratesTakuya Osada, Göran Rådegran
Transplantation Reviews (Orlando, Fla.)|September 4, 2017
Osteoporosis following heart transplantation and immunosuppressive therapyEveline Löfdahl, Göran Rådegran
ERJ Open Research|November 17, 2018
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertensionHabib Bouzina, Göran Rådegran
Pageof 13